CharacterBench: Benchmarking Character Customization of Large Language ModelsJinfeng Zhou, Yongkang Huang, Bosi Wen et al.
Character-based dialogue (aka role-playing) enables users to freely customize characters for interaction, which often relies on LLMs, raising the need to evaluate LLMs' character customization capability. However, existing benchmarks fail to ensure a robust evaluation as they often only involve a single character category or evaluate limited dimensions. Moreover, the sparsity of character features in responses makes feature-focused generative evaluation both ineffective and inefficient. To address these issues, we propose CharacterBench, the largest bilingual generative benchmark, with 22,859 human-annotated samples covering 3,956 characters from 25 detailed character categories. We define 11 dimensions of 6 aspects, classified as sparse and dense dimensions based on whether character features evaluated by specific dimensions manifest in each response. We enable effective and efficient evaluation by crafting tailored queries for each dimension to induce characters' responses related to specific dimensions. Further, we develop CharacterJudge model for cost-effective and stable evaluations. Experiments show its superiority over SOTA automatic judges (e.g., GPT-4) and our benchmark's potential to optimize LLMs' character customization. Our repository is at https://github.com/thu-coai/CharacterBench.
SocialEval: Evaluating Social Intelligence of Large Language ModelsJinfeng Zhou, Yuxuan Chen, Yihan Shi et al.
LLMs exhibit promising Social Intelligence (SI) in modeling human behavior, raising the need to evaluate LLMs' SI and their discrepancy with humans. SI equips humans with interpersonal abilities to behave wisely in navigating social interactions to achieve social goals. This presents an operational evaluation paradigm: outcome-oriented goal achievement evaluation and process-oriented interpersonal ability evaluation, which existing work fails to address. To this end, we propose SocialEval, a script-based bilingual SI benchmark, integrating outcome- and process-oriented evaluation by manually crafting narrative scripts. Each script is structured as a world tree that contains plot lines driven by interpersonal ability, providing a comprehensive view of how LLMs navigate social interactions. Experiments show that LLMs fall behind humans on both SI evaluations, exhibit prosociality, and prefer more positive social behaviors, even if they lead to goal failure. Analysis of LLMs' formed representation space and neuronal activations reveals that LLMs have developed ability-specific functional partitions akin to the human brain.
2.3QMMay 21, 2025
An Inclusive Foundation Model for Generalizable Cytogenetics in Precision OncologyChangchun Yang, Weiqian Dai, Yilan Zhang et al.
Chromosome analysis is vital for diagnosing genetic disorders and guiding cancer therapy decisions through the identification of somatic clonal aberrations. However, developing an AI model are hindered by the overwhelming complexity and diversity of chromosomal abnormalities, requiring extensive annotation efforts, while automated methods remain task-specific and lack generalizability due to the scarcity of comprehensive datasets spanning diverse resource conditions. Here, we introduce CHROMA, a foundation model for cytogenomics, designed to overcome these challenges by learning generalizable representations of chromosomal abnormalities. Pre-trained on over 84,000 specimens (~4 million chromosomal images) via self-supervised learning, CHROMA outperforms other methods across all types of abnormalities, even when trained on fewer labelled data and more imbalanced datasets. By facilitating comprehensive mapping of instability and clonal leisons across various aberration types, CHROMA offers a scalable and generalizable solution for reliable and automated clinical analysis, reducing the annotation workload for experts and advancing precision oncology through the early detection of rare genomic abnormalities, enabling broad clinical AI applications and making advanced genomic analysis more accessible.